Sequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis.

Katsarolis A, Anastasiou M, Pouliakis A, Psyrri A, Fountzilas E

Open source

DOI
10.1007/s00228-026-04218-0
Published
2026 Nov 9
Container
European journal of clinical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-026-04218-0,
  title = {Sequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis.},
  author = {Katsarolis A and Anastasiou M and Pouliakis A and Psyrri A and Fountzilas E},
  year = {2026},
  journal = {European journal of clinical pharmacology},
  doi = {10.1007/s00228-026-04218-0},
  url = {https://doi.org/10.1007/s00228-026-04218-0}
}

RIS

TY  - JOUR
TI  - Sequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis.
AU  - Katsarolis A
AU  - Anastasiou M
AU  - Pouliakis A
AU  - Psyrri A
AU  - Fountzilas E
PY  - 2026
JO  - European journal of clinical pharmacology
DO  - 10.1007/s00228-026-04218-0
UR  - https://doi.org/10.1007/s00228-026-04218-0
ER  - 

APA

A, K., M, A., A, P., A, P., & E, F. (2026). Sequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis.. European journal of clinical pharmacology. https://doi.org/10.1007/s00228-026-04218-0

Source records